Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioLine RX Ltd (NASDAQ:BLRX)

0.9099
Delayed Data
As of 1:04pm ET
 -0.0099 / -1.08%
Today’s Change
0.71
Today|||52-Week Range
1.42
-1.10%
Year-to-Date
BioLineRx (BLRX) Starts Cancer Study on BL-8040+Keytruda
Jan 19 / Zacks.com - Paid Partner Content